Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Jennifer Quint, Jukka Montonen, Dave Singh, Herbert Wachtel, Sharon Attick, Swetha Palli, Monica Frazer, Vincent Willey & Glenn Giessel. (2022) New insights into the optimal management of COPD: extracts from CHEST 2021 annual meeting (October 17–20, 2021). Expert Review of Respiratory Medicine 16:4, pages 485-493.
Read now
Read now
Piotr Damiański, Grzegorz Kardas, Michał Panek, Piotr Kuna & Maciej Kupczyk. (2022) Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directions. Expert Opinion on Drug Safety 21:4, pages 499-515.
Read now
Read now
Subash S Heraganahally, Tarun R Ponneri, Timothy P Howarth & Helmi Ben Saad. (2021) The Effects of Inhaled Airway Directed Pharmacotherapy on Decline in Lung Function Parameters Among Indigenous Australian Adults With and Without Underlying Airway Disease. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2707-2720.
Read now
Read now
Miguel Roman-Rodriguez & Alan Kaplan. (2021) GOLD 2021 Strategy Report: Implications for Asthma–COPD Overlap. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1709-1715.
Read now
Read now
I. Satia, M. Wahab, E. Kum, H. Kim, P. Lin, A. Kaplan, P. Hernandez, J. Bourbeau, L. P. Boulet & S. K. Field. (2021) Chronic cough: Investigations, management, current and future treatments. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 5:6, pages 404-416.
Read now
Read now
Marco Contoli, Luca Morandi, Fabiano Di Marco & Mauro Carone. (2021) A perspective for chronic obstructive pulmonary disease (COPD) management: six key clinical questions to improve disease treatment. Expert Opinion on Pharmacotherapy 22:4, pages 427-437.
Read now
Read now
Ji-Ho Lee, You Hyun Park, Dae Ryong Kang, Seok Jeong Lee, Myoung Kyu Lee, Sang-Ha Kim, Suk Joong Yong & Won-Yeon Lee. (2020) Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3397-3406.
Read now
Read now
Donald P Tashkin. (2020) Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3105-3122.
Read now
Read now
Thomas P Lodise, Jingyi Li, Hitesh N Gandhi, Gerald O’Brien & Sanjay Sethi. (2020) Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2889-2900.
Read now
Read now
Jaco Voorham, Simonetta Baldi, Luigi Santoro, Marjan Kerkhof, Marco Contoli, Leonardo M Fabbri, Huib A M Kerstjens, Jose Luis López-Campos, Nicolas Roche, Dave Singh, Claus F Vogelmeier & David B Price. (2020) Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2739-2750.
Read now
Read now
Motokazu Kato, Keisuke Tomii, Kenichi Hashimoto, Yasuko Nezu, Takeo Ishii, C Elaine Jones, Sally Kilbride, Annette S Gross, Christine S Clifton & David A Lipson. (2019) The IMPACT Study – Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI And UMEC/VI In Patients With COPD: Efficacy And Safety In A Japanese Population. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2849-2861.
Read now
Read now
Timothy E Albertson, Willis S Bowman, Richart W Harper, Regina M Godbout & Susan Murin. (2019) Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1251-1265.
Read now
Read now
Articles from other publishers (40)
Eung Gu Lee, Youlim Kim, Yong Il Hwang, Kwang Ha Yoo, So Eun Lee, Kyung Yoon Jung, Doik Lee, Yong Bum Park & Chin Kook Rhee. (2023) Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD. Scientific Reports 13:1.
Crossref
Crossref
Suh-Young Lee, Soon Ho Yoon & Hyunsook Hong. (2023) A Critical Systematic Review for Inhaled Corticosteroids on Lung Cancer Incidence: Not Yet Concluded Story. Tuberculosis and Respiratory Diseases 86:2, pages 120-132.
Crossref
Crossref
Frida Vilstrup, Christian Kjer Heerfordt, Peter Kamstrup, Caroline Hedsund, Tor Biering-Sørensen, Rikke Sørensen, Shailesh Kolekar, Ole Hilberg, Lars Pedersen, Thomas Kromann Lund, Tobias Wirenfeldt Klausen, Kristoffer Grundtvig Skaarup, Josefin Eklöf, Pradeesh Sivapalan & Jens-Ulrik Stæhr Jensen. (2023) Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study. BMJ Open Respiratory Research 10:1, pages e001428.
Crossref
Crossref
A. G. Kadushkin, A. D. Tahanovich, T. S. Kolesnikova & A. V. Khadasouskaya. (2023) Effect of budesonide and azithromycin on the chemotaxis of blood monocytes and lymphocytes in patients with chronic obstructive pulmonary disease. Health and Ecology Issues 19:4, pages 103-110.
Crossref
Crossref
Ralph Brattsand & Olof Selroos. (2022) May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?. Pulmonary Pharmacology & Therapeutics 77, pages 102167.
Crossref
Crossref
Ellenmae W. X. Leong & Ruowen Ge. (2022) Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics. Biomedicines 10:9, pages 2179.
Crossref
Crossref
Iseul Yu, Sunmin Park, Se Hwa Hong, Min-Seok Chang, Seok Jeong Lee, Suk Joong Yong, Won-Yeon Lee, Sang-Ha Kim & Ji-Ho Lee. (2022) Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study. Journal of Personalized Medicine 12:7, pages 1189.
Crossref
Crossref
Hilla Mills, Ronald Acquah, Nova Tang, Luke Cheung, Susanne Klenk, Ronald Glassen, Magali Pirson, Alain Albert, Duong Trinh Hoang & Thang Nguyen Van. (2022) Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD). Emergency Medicine International 2022, pages 1-5.
Crossref
Crossref
Domenico Maurizio Toraldo, Emanuele Rizzo & Luana Conte. (2022) Effects of inhaled corticosteroids (ICS) on lung microbiota and local immune response in long-term treatment of chronic obstructive pulmonary disease (COPD): utility of titration and therapeutic index. Naunyn-Schmiedeberg's Archives of Pharmacology 395:7, pages 849-858.
Crossref
Crossref
Antony Wright, Helene Vioix, Shamika de Silva, Sue Langham, Jennifer Cook, Toby Capstick & Jennifer K Quint. (2022) Cost–consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK. BMJ Open 12:6, pages e059158.
Crossref
Crossref
David Luque-Paz, Pierre Tattevin, Paul Loubet, François Bénézit, Vincent Thibault, Fabrice Lainé, Philippe Vanhems, Selilah Amour, Bruno Lina, Xavier Duval, Anne-Sophie L’Honneur, Nadhira Fidouh, Christine Vallejo, Sophie Alain, Florence Galtier, Vincent Foulongne, Gisèle Lagathu, Nezha Lenzi, Zineb Lesieur, Odile Launay, Stéphane Jouneau, O. Launay, N. Lenzi, Z. Lesieur, P. Loulergue, S. Momcilovic, J. P. Mira, N. Marin, J. Charpentier, A. Regent, R. Kanaan, F. Dumas, B. Doumenc, A. S. L’Honneur, M. Lachatre, T. Szwebel, J. Kansao, Y. Costa, X. Duval, J. F. Alexandra, H. Becheur, K. Belghalem, J. Bernard, A. Bleibtreu, M. Boisseau, R. Bories, O. Brugiere, F. Brunet, C. Burdet, E. Casalino, M. Caseris, C. Chansiaux, M. Chauchard, P. Chavance, C. Choquet, A. Cloppet-Fontaine, L. Colosi, B. Couset, B. Crestani, F. Crocket, A. Debit, Delanoe, V. Descamps, P. Dieude, A. Dossier, N. Douron, E. Dupeyrat, N. Emeyrat, C. Fernet, T. Goulenok, S. Harent, R. Jouenne, A. Justet, M. Lachatre, A. Leleu, I. Lerat, M. Lilamand, H. Mal, A. Marceau, A.-C. Metivier, K. Oplelatora, T. Papo, A.-L. Pelletier, L. Pereira, P. Pradere, Prommier, P. Ralainnazava, M. Ranaivoision, A. Raynaud-Simon, C. Rioux, K. Sacre, V. Verry, V. Vuong, Y. Yazdapanah, N. Houhou, F. Galtier, P. Géraud, V. Driss, V. Maugueret, L. Crantelle, C. Agostini, M. Ray, F. Letois, T. Mura, C. Serrand, C. Agostini, S. Noslier, A. Giordano, H. Chevassus, E. Nyiramigisha, C. Merle, A. Bourdin, A. Konaté, X. Capdevilla, G. Du Cailar, A. Terminet, H. Blain, M. S. Leglise, A. Le Quellec, P. Corne, L. Landreau, K. Klouche, A. Bourgeois, M. Sebbane, G. Mourad, H. Leray, V. Foulongne, D. Postil, S. Alcolea, E. Couve-Deacon, S. Rogez, S. Amour, P. Vanhems, L. Argaud, M. Cour, R. Hernu, M. Simon, T. Baudry, K. Tazarourte, C. Bui-Xuan, J. Fattoum, B. Lina, M. Valette, F. Lainé, V. Thibault, S. Rochas, S. Cochennec, E. Thébault, G. Lagathu, S. Jouneau, M. Revest, F. Bénézit, M. Sébillotte, A. Le Bot, M. Baldeyrou, S. Patrat-Delon, M. Cailleaux, C. Pronier & P. Tattevin. (2022) Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study. Scientific Reports 12:1.
Crossref
Crossref
Holly Mitzel, Dakota Brown, Morgan Thomas, Byrne Curl, Mackenzie Wild, Andrea Kelsch, Judge Muskrat, Abulquasem Hossain, Ken Ryan, Olawale Babalola, Madison Burgard & Masfique Mehedi. (2022) Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD. Medicina 58:2, pages 254.
Crossref
Crossref
Damian Jozef Flis, Emilia Gabriela Bialobrodzka, Ewa Aleksandra Rodziewicz-Flis, Zbigniew Jost, Andzelika Borkowska, Wieslaw Ziolkowski & Jan Jacek Kaczor. (2022) The Effect of Long-Lasting Swimming on Rats Skeletal Muscles Energy Metabolism after Nine Days of Dexamethasone Treatment. International Journal of Molecular Sciences 23:2, pages 748.
Crossref
Crossref
Md Mohiuddin & Kazuo Kasahara. (2022) Potential therapeutic role of budesonide to reduce COVID-19 severity. Journal of Infection and Public Health 15:1, pages 109-111.
Crossref
Crossref
Caina Xu, Huayu Tian & Xuesi Chen. 2022. Gene Delivery. Gene Delivery
61
73
.
Imran Sulaiman, Jun-Chieh J. Tsay & Leopoldo N. Segal. 2022. The Microbiome in Respiratory Disease. The Microbiome in Respiratory Disease
199
214
.
K. A. Zykov, V. V. Vikentyev, I. V. Goloborodova, I. I. Kopchenov, O. V. Bondarec, T. F. Guseva & E. I. Sokolov. (2021) The use of short-acting bronchodilators in patients with chronic bronchoobstructive pathology at the present stage. Meditsinskiy sovet = Medical Council:12, pages 91-99.
Crossref
Crossref
Robert P. Young & Raewyn J. Scott. (2021) Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk?. European Respiratory Journal 58:1, pages 2100342.
Crossref
Crossref
Adi Halili. (2021) Physical therapy for the treatment of respiratory issues using Systemic Manual Therapy protocols. Journal of Bodywork and Movement Therapies 27, pages 113-126.
Crossref
Crossref
Beatriz Ballester, Javier Milara & Julio Cortijo. (2021) The role of mucin 1 in respiratory diseases. European Respiratory Review 30:159, pages 200149.
Crossref
Crossref
Anjali Trivedi, Meraj A. Khan, Geetanjali Bade & Anjana Talwar. (2021) Orchestration of Neutrophil Extracellular Traps (Nets), a Unique Innate Immune Function during Chronic Obstructive Pulmonary Disease (COPD) Development. Biomedicines 9:1, pages 53.
Crossref
Crossref
Yinghan Chan, Sin Wi Ng, Hui Shan Liew, Lesley Jia Wei Pua, Laura Soon, Jun Sing Lim, Kamal Dua & Dinesh Kumar Chellappan. 2021. Medicinal Plants for Lung Diseases. Medicinal Plants for Lung Diseases
47
84
.
Caina Xu, Huayu Tian & Xuesi Chen. 2021. Gene Delivery. Gene Delivery
1
14
.
Elvis M. Irusen & Thandeka D. Malange. (2020) Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids. South African Family Practice 62:1.
Crossref
Crossref
Aivaras Cepelis, Ben M. Brumpton, Lars E. Laugsand, Arnulf Langhammer, Imre Janszky & Linn B. Strand. (2020) Asthma, asthma control and risk of ischemic stroke: The HUNT study. Respiratory Medicine: X 2, pages 100013.
Crossref
Crossref
Toral J. Parikh, Krysttel C. Stryczek, Chris Gillespie, George G. Sayre, Laura Feemster, Edmunds Udris, Barbara Majerczyk, Seppo T. Rinne, Renda Soylemez Wiener, David H. Au & Christian D. Helfrich. (2020) Provider anticipation and experience of patient reaction when deprescribing guideline discordant inhaled corticosteroids. PLOS ONE 15:9, pages e0238511.
Crossref
Crossref
Steven P Cohen, W Michael Hooten & Christopher R Phillips. (2020) Pain Management During COVID-19 and Steroids: Striking a Balance. Pain Medicine 21:8, pages 1731-1733.
Crossref
Crossref
Andrea Weiss, Sandra Porter, Dmitry Rozenberg, Erin O'Connor, Tiffany Lee, Meyer Balter & Kirsten Wentlandt. (2020) Chronic Obstructive Pulmonary Disease: A Palliative Medicine Review of the Disease, Its Therapies, and Drug Interactions. Journal of Pain and Symptom Management 60:1, pages 135-150.
Crossref
Crossref
José Luis Lopez-Campos, Marc Miravitlles, David de la Rosa Carrillo, Rafael Cantón, Juan Jose Soler-Cataluña & Miguel Angel Martinez-Garcia. (2020) Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine 9:6, pages 1639.
Crossref
Crossref
Miguel Angel Martinez-Garcia, Rosa Faner, Grace Oscullo, David de la Rosa, Juan-Jose Soler-Cataluña, Marta Ballester & Alvar Agusti. (2020) Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis. American Journal of Respiratory and Critical Care Medicine 201:9, pages 1078-1085.
Crossref
Crossref
Donald P. Tashkin. (2020) Further Evidence of Varying Risks and Benefits of Different Inhaled Corticosteroid/Long-acting Beta-agonist Combinations in COPD. Chest 157:5, pages 1067-1069.
Crossref
Crossref
Joyonna Carrie Gamble-George, Christopher T. Longenecker, Allison R. Webel, David H. Au, Arleen F. Brown, Hayden Bosworth, Kristina Crothers, William E. Cunningham, Kevin A. Fiscella, Alison B. Hamilton, Christian D. Helfrich, Joseph A. Ladapo, Amneris Luque, Jonathan N. Tobin & Gail E. Wyatt. (2020) ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research. Progress in Cardiovascular Diseases 63:2, pages 79-91.
Crossref
Crossref
Lina Dahabiyeh, Abeer Malkawi, Xiaohang Wang, Dilek Colak, Ahmed Mujamammi, Essa Sabi, Liang Li, Majed Dasouki & Anas Abdel Rahman. (2020) Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical Isotope Labeling LC-MS Analysis. Metabolites 10:2, pages 42.
Crossref
Crossref
Angela Maria Sousa, Thiago Ramos Grigio, Hazem Adel Ashmawi & Ulysses Ribeiro Júnior. (2020) Cancer pain treatment during the COVID-19 pandemic: institutional recommendations. Clinics 75, pages e2208.
Crossref
Crossref
Lisa G. Pont, Kamal Dua & Kylie A. Williams. 2020. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
33
39
.
Sue Langham, Jen Lewis, Nick Pooley, Nina Embleton, Julia Langham, MeiLan K. Han & James D. Chalmers. (2019) Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review. Respiratory Research 20:1.
Crossref
Crossref
Jürgen Knobloch, David Jungck, Juliane Kronsbein, Erich Stoelben, Kazuhiro Ito & Andrea Koch. (2019) LABAs and p38MAPK Inhibitors Reverse the Corticosteroid-Insensitivity of IL-8 in Airway Smooth Muscle Cells of COPD. Journal of Clinical Medicine 8:12, pages 2058.
Crossref
Crossref
Antonio Molino, Michela Terlizzi, Chiara Colarusso, Antonietta Rossi, Pasquale Somma, Alessandro Saglia, Aldo Pinto & Rosalinda Sorrentino. (2019) AIM2/IL-1α/TGF-β Axis in PBMCs From Exacerbated Chronic Obstructive Pulmonary Disease (COPD) Patients Is Not Related to COX-2-Dependent Inflammatory Pathway. Frontiers in Physiology 10.
Crossref
Crossref
I. D. Pelevina, N. L. Shaporova, O. V. Dudina, V. N. Yablonskaya & O. A. Lazovskaya. (2019) Management of chronic obstructive pulmonary disease patients quitting smoking: optimization the basic therapy. Russian Pulmonology 29:1, pages 52-60.
Crossref
Crossref
I. V. Leshchenko. (2018) Possibilities and limitations of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease. Russian Pulmonology 28:5, pages 602-612.
Crossref
Crossref